ECASS-II: intravenous alteplase in acute ischaemic stroke Kennedy R Lees The Lancet Volume 353, Issue 9146, Pages 65-66 (January 1999) DOI: 10.1016/S0140-6736(05)74846-7 Copyright © 1999 Elsevier Ltd Terms and Conditions
Figure Meta-analysis of the randomised trials of thrombolysis with tissue plasminogen activator in which alteplase was given within 6 h of acute ischaemic stroke after exclusion of intracerebral bleeding by CT scanning The combined endpoint of death of disability is based on modified Rankin grade 3 or higher. The Lancet 1999 353, 65-66DOI: (10.1016/S0140-6736(05)74846-7) Copyright © 1999 Elsevier Ltd Terms and Conditions